Literature DB >> 34250402

BCR-ABL+ Chronic Myeloid Leukemia Arising in a Family With Inherited ANKRD26-Related Thrombocytopenia.

Aaron M Tsumura1, Brian J Druker2,3, Diana Brewer2, Richard Press2,3, Theodore P Braun2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34250402      PMCID： PMC8232552          DOI： 10.1200/PO.20.00318

Source DB:  PubMed          Journal:  JCO Precis Oncol        ISSN： 2473-4284


× No keyword cloud information.
  11 in total

Review 1.  The biology of chronic myeloid leukemia.

Authors:  S Faderl; M Talpaz; Z Estrov; S O'Brien; R Kurzrock; H M Kantarjian
Journal:  N Engl J Med       Date:  1999-07-15       Impact factor: 91.245

2.  No familial aggregation in chronic myeloid leukemia.

Authors:  Magnus Björkholm; Sigurdur Y Kristinsson; Ola Landgren; Lynn R Goldin
Journal:  Blood       Date:  2013-07-18       Impact factor: 22.113

Review 3.  Familial myelodysplastic syndromes: a review of the literature.

Authors:  Elena Liew; Carolyn Owen
Journal:  Haematologica       Date:  2011-05-23       Impact factor: 9.941

Review 4.  Response and Resistance to BCR-ABL1-Targeted Therapies.

Authors:  Theodore P Braun; Christopher A Eide; Brian J Druker
Journal:  Cancer Cell       Date:  2020-04-13       Impact factor: 31.743

5.  Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status.

Authors:  M Schmidt; J Rinke; V Schäfer; S Schnittger; A Kohlmann; E Obstfelder; C Kunert; J Ziermann; N Winkelmann; E Eigendorff; T Haferlach; C Haferlach; A Hochhaus; T Ernst
Journal:  Leukemia       Date:  2014-09-12       Impact factor: 11.528

6.  Mutations in the 5' UTR of ANKRD26, the ankirin repeat domain 26 gene, cause an autosomal-dominant form of inherited thrombocytopenia, THC2.

Authors:  Tommaso Pippucci; Anna Savoia; Silverio Perrotta; Núria Pujol-Moix; Patrizia Noris; Giovanni Castegnaro; Alessandro Pecci; Chiara Gnan; Francesca Punzo; Caterina Marconi; Samuele Gherardi; Giuseppe Loffredo; Daniela De Rocco; Saverio Scianguetta; Serena Barozzi; Pamela Magini; Valeria Bozzi; Luca Dezzani; Mariateresa Di Stazio; Marcella Ferraro; Giovanni Perini; Marco Seri; Carlo L Balduini
Journal:  Am J Hum Genet       Date:  2011-01-07       Impact factor: 11.025

7.  Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families.

Authors:  Patrizia Noris; Silverio Perrotta; Marco Seri; Alessandro Pecci; Chiara Gnan; Giuseppe Loffredo; Nuria Pujol-Moix; Marco Zecca; Francesca Scognamiglio; Daniela De Rocco; Francesca Punzo; Federica Melazzini; Saverio Scianguetta; Maddalena Casale; Caterina Marconi; Tommaso Pippucci; Giovanni Amendola; Lucia D Notarangelo; Catherine Klersy; Elisa Civaschi; Carlo L Balduini; Anna Savoia
Journal:  Blood       Date:  2011-04-05       Impact factor: 22.113

8.  ANKRD26-related thrombocytopenia and myeloid malignancies.

Authors:  Patrizia Noris; Remi Favier; Marie-Christine Alessi; Amy E Geddis; Shinji Kunishima; Paula G Heller; Paola Giordano; Karen Y Niederhoffer; James B Bussel; Gian Marco Podda; Nicola Vianelli; Rogier Kersseboom; Alessandro Pecci; Chiara Gnan; Caterina Marconi; Anne Auvrignon; William Cohen; Jennifer C Yu; Akihiro Iguchi; Allison Miller Imahiyerobo; Francoise Boehlen; Dorsaf Ghalloussi; Daniela De Rocco; Pamela Magini; Elisa Civaschi; Ginevra Biino; Marco Seri; Anna Savoia; Carlo L Balduini
Journal:  Blood       Date:  2013-09-12       Impact factor: 22.113

Review 9.  Genetic compensation of RUNX family transcription factors in leukemia.

Authors:  Yasuhiko Kamikubo
Journal:  Cancer Sci       Date:  2018-08       Impact factor: 6.716

10.  Thrombocytopenia-associated mutations in the ANKRD26 regulatory region induce MAPK hyperactivation.

Authors:  Dominique Bluteau; Alessandra Balduini; Nathalie Balayn; Manuela Currao; Paquita Nurden; Caroline Deswarte; Guy Leverger; Patrizia Noris; Silverio Perrotta; Eric Solary; William Vainchenker; Najet Debili; Remi Favier; Hana Raslova
Journal:  J Clin Invest       Date:  2014-01-16       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.